Syapse
OverviewSuggest Edit
Syapse is a company that provides a precision medicine data platform enabling healthcare providers to use molecular profiling to diagnose and treat patients. It offers data intelligence, deep learning algorithms such as line-of-therapy (LoT), time to next treatment (TTNT), and overall survival (OS), and other solutions.
| Type | Private | |
| Founded | 2008 | |
| HQ | San Francisco, CA, US | Map |
| Website | syapse.com | |
| Employee Ratings | More | |
| Overall Culture | A+ | More |
Recent NewsAll News
- Syapse Announces Changes to Board of Directors, Adding Michael Mentesana and Elevating Frank Williams to Chairman Role
- Main Line Health Collaborates with Syapse, Bringing Clinical Trial Opportunities to Patients with Cancer in Philadelphia Region
- Syapse Extends Collaboration with Pfizer to Continue to Generate Real-World Evidence in Breast Cancer
- Illumina and Syapse Partner on Research to Evaluate Large Panel Biomarker Testing Patterns Across US Community Oncology Practices
Key People/Management at Syapse
Ken Tarkoff
Chief Executive Officer, Director
Tony Loeser
Co-Founder and Chief Technology Officer
Jonathan Hirsch
Founder and President
David Pomerantz
Chief Commercial Officer
Thomas Brown
Chief Medical Officer
Fletcher Payne
Chief Financial Officer
Syapse Office Locations
Syapse has offices in San Francisco and Radnor
San Francisco, CA, US (HQ)
303 2nd St, San Francisco
Radnor, PA, US
100 Matsonford Rd Suite 100
Syapse Financials and Metrics
Summary Metrics
Founding Date | 2008 |
Syapse total Funding | $99.6 m |
Syapse latest funding size | $30 m |
Time since last funding | 2 years ago |
Syapse investors | Safeguard Scientifics, GE Ventures, Merck Global Health Innovation Fund, Roche Venture Fund, Amgen Ventures, Ascension Ventures, Social Capital, Social Capital Partners, Medidata Solutions, Intermountain Healthcare Innovation Fund, Intermountain Ventures, Revelation Alpine, Roche Finance |
Syapse's latest funding round in May 2020 was reported to be $30 m. In total, Syapse has raised $99.6 m
Syapse Cybersecurity Score
Syapse Online and Social Media Presence
1.8k Twitter followers
Syapse has 1.8k Twitter Followers. The number of followers has increased 0.1% month over month and increased 0.8% quarter over quarter
Syapse's Trends
Twitter Engagement Stats for @Syapse
1.8k
Tweets
383
Following
1.8k
Followers
6
Tweets last 30 days
1.8
Avg. likes per Tweet
83.3%
Tweets with engagement
Syapse Company Culture
Overall Culture
A+
91/100
CEO Rating
A+
95/100
Compensation
A+
96/100
Diversity
A+
93/100
Syapse News and Updates
March 31, 2022
Syapse Announces Changes to Board of Directors, Adding Michael Mentesana and Elevating Frank Williams to Chairman Role
SAN FRANCISCO, March 31, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced that long-time board member and health industry veteran Frank Williams has been named as…
March 22, 2022
Main Line Health Collaborates with Syapse, Bringing Clinical Trial Opportunities to Patients with Cancer in Philadelphia Region
Leveraging The Syapse Learning Health Network, and real-world data platform, Main Line Health will optimize its ability to match patients Leveraging The Syapse Learning Health Network, and real-world data platform, Main Line Health will optimize its ability to match patients
January 20, 2022
Syapse Extends Collaboration with Pfizer to Continue to Generate Real-World Evidence in Breast Cancer
Syapse will continue to identify, validate, and address discrepancies in real-world data, producing an accurate and fully contextualized narrative of a patient’s experience Syapse will continue to identify, validate, and address discrepancies in real-world data, producing an accurate and fully conte…
January 04, 2022
Illumina and Syapse Partner on Research to Evaluate Large Panel Biomarker Testing Patterns Across US Community Oncology Practices
The collaboration will explore the uptake and actionability of comprehensive genomic profiling in patients with advanced cancers The collaboration will explore the uptake and actionability of comprehensive genomic profiling in patients with advanced cancers
December 17, 2021
Syapse Recognized by Comparably Awards Across Four Categories
The company’s employees rated Syapse as a Best Company Culture, Best CEO, Best Company for Women, and Best Company for Diversity The company’s employees rated Syapse as a Best Company Culture, Best CEO, Best Company for Women, and Best Company for Diversity
December 15, 2021
Bayhealth Collaborates with Syapse, Bringing Data-Driven Approach to Oncology Care
Leveraging Syapse’s real-world data platform, Bayhealth is optimizing its oncology data to meet patients where they are with industry-leading cancer care Leveraging Syapse’s real-world data platform, Bayhealth is optimizing its oncology data to meet patients where they are with industry-leading canc…
Syapse Frequently Asked Questions
When was Syapse founded?
Syapse was founded in 2008.
Who are Syapse key executives?
Syapse's key executives are Ken Tarkoff, Tony Loeser and Jonathan Hirsch.
How many employees does Syapse have?
Syapse has 226 employees.
Who are Syapse competitors?
Competitors of Syapse include Flatiron Health, Orion Health and LungLife AI.
Where is Syapse headquarters?
Syapse headquarters is located at 303 2nd St, San Francisco, San Francisco.
Where are Syapse offices?
Syapse has offices in San Francisco and Radnor.
How many offices does Syapse have?
Syapse has 2 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies